Prolymphocytic leukemia. Serial responses to therapy

J. F. Swift, H. G. Wold, David R Gandara, J. Redmond, C. B. George

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Prolymphocytic leukemia is a rare lymphoproliferative disorder characterized by marked lymphocytosis, massive splenomegaly, minimal lymphadenopathy, and poor prognosis. Previous reports have noted very short survival, and poor response to single agent alkylator chemotherapy. A small number of reports have shown response to combination chemotherapy regimens including Adriamycin (doxorubicin). A case of prolymphocytic leukemia with serial responses to combination chemotherapy and splenectomy resulting in significant prolongation of survival is reported.

Original languageEnglish (US)
Pages (from-to)978-980
Number of pages3
Issue number6
StatePublished - 1984
Externally publishedYes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Prolymphocytic leukemia. Serial responses to therapy'. Together they form a unique fingerprint.

Cite this